Mylan Launches Generic Version of Pfizer’s Zyvox
By

Mylan N.V. has launched in the US linezolid tablets, 600 mg, which is the generic version of Pfizer’s Zyvox tablets. Mylan received final approval from the US Food and Drug Administration for its abbreviated new drug application for this product, which is indicated in adults and children for the treatment of certain infections caused by susceptible Gram-positive bacteria.

Linezolid tablets, 600 mg, had US sales of approximately $457.8 million for the 12 months ending Sept. 30, 2015, according to IMS Health, and as reported by Mylan.

Source: Mylan

Leave a Reply

Your email address will not be published.